XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED INCOME STATEMENT - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Revenues $ 594,781 $ 571,414
Cost of service, inclusive of depreciation 334,050 321,537
General and administrative expenses:    
Salaries and benefits 131,968 127,946
Non-cash compensation 6,223 7,433
Merger-related expenses 16,769 20,667
Depreciation and amortization 4,447 4,271
Other 57,965 57,941
Total operating expenses 551,422 539,795
Operating income 43,359 31,619
Other income (expense):    
Interest income 2,873 1,727
Interest expense 6,422 8,119
Equity in earnings from equity method investments 1,794 910
Gain on equity method investment 48,093 0
Miscellaneous, net 1,508 1,090
Total other income (expense), net 47,846 (4,392)
Income before income taxes 91,205 27,227
Income tax expense (29,384) (12,633)
Net income 61,821 14,594
Net income attributable to noncontrolling interests (809) (194)
Net income attributable to Amedisys, Inc. $ 61,012 $ 14,400
Basic earnings per common share:    
Net income attributable to Amedisys, Inc. common stockholders $ 1.86 $ 0.44
Weighted average shares outstanding, basic (shares) 32,793 32,670
Diluted earnings per common share:    
Net income attributable to Amedisys, Inc. common stockholders $ 1.84 $ 0.44
Weighted average shares outstanding, diluted (shares) 33,218 32,979